Related Experiment Video
Updated: Apr 7, 2026
05:09
Urethral Stricture Induction Followed by Buccal Mucosa Graft Urethroplasty in a Rat Model
Published on: April 28, 2023
1.8K
[Medication: 15 years 'EU-directive orphan drugs'].
Bulletin - Cercle Benelux D'Histoire De La Pharmacie
|July 4, 2015
Summary
Patient compliance with oral orphan drugs is a challenge in Belgium, despite being free and life-saving. Hospital pharmacies face strict guidelines for compounding parenteral orphan medications, especially for ultra-rare conditions.
Area of Science:
- Pharmacology
- Health Policy
- Drug Management
Context:
- Belgium's pharmaceutical landscape 15 years post-EU Orphan Drug Directive.
- Challenges in orphan drug access and utilization.
- The role of national policies in rare disease treatment.
Purpose:
- To evaluate the compounding, dispensing, and reimbursement of orphan drugs in Belgium.
- To identify challenges in patient compliance with oral orphan medications.
- To outline the requirements for compounding parenteral orphan drugs.
Summary:
- Oral orphan medications, though life-saving and free, present significant patient compliance issues requiring pharmacist intervention.
- Parenteral orphan drugs necessitate specialized compounding within hospital pharmacies adhering to strict handling and storage protocols.
- Compounding for ultra-rare disorders may involve chemical-grade ingredients lacking pharmaceutical monographs, raising quality and safety considerations.
Impact:
- Highlights the critical role of dispensing pharmacists in improving patient adherence to orphan drugs.
- Underscores the complexities and stringent requirements for hospital pharmacy compounding of specialized medications.
- Identifies cost-effectiveness as an ongoing challenge in the provision of orphan drugs for rare diseases.
Related Concept Videos
01:02Prescription, Nonprescription and Orphan Drugs
1.4K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.4K
01:26FDA Approved Drugs: Changes to Approved Drugs
330
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
330
01:25Drug Regulation
3.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.3K
01:28Drug Products: Biologics, Biosimilars and Interchangeables
357
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
357
01:17Drug Nomenclature
3.7K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
3.7K
01:26Drug Administration and Therapy Phases: Overview
1.7K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.7K